Optiscan Targets US Rollout After Filing Two Human Device Applications
OIL: $0.145 -6.45% · MC: $162M
Optiscan Imaging says it filed US regulatory applications for its InForm and InVue human imaging devices in October, with clearances anticipated from October next year, subject to review. The company plans to place consoles at up to five US reference sites before expanding to its first customer accounts. Its first own-brand clinical product, InSpecta, launched in the US veterinary market in July.

Comments